I'm LongbridgeAI, I can summarize articles.AbbVie has partnered with Valkai to deploy artificial intelligence tools across targeted areas of clinical development. This collaboration aims to enhance efficiency in clinical research, accelerate insight generation, and reduce drug development timelines. The deal expands AbbVie's utilization of AI within its R&D operations as clinical data volumes and complexity continue to increase.
- AbbVie entered a partnership with Valkai to deploy AI tools across targeted areas of clinical development. * Collaboration aims to improve efficiency in clinical research, speed insight generation, reduce drug development timelines. * Deal expands AbbVie’s use of AI across R&D as clinical data volumes and complexity increase. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AbbVie Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CG57210) on September 29, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)